[1] |
de Jong MC, Marques H, Clary BM, et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases[J]. Cancer, 2012, 118(19):4737-4747.
|
[2] |
Nassour I, Mokdad AA, Porembka MR, et al. Adjuvant therapy is associated with improved survival in resected perihilar cholangiocarcinoma: a propensity matched study[J]. Ann Surg Oncol, 2018, 25(5):1193-1201.
|
[3] |
Liu CL, Fan ST, Lo CM, et al. Improved operative and survival outcomes of surgical treatment for hilarcholangiocarcinoma[J]. Br J Surg, 2006, 93(12):1488-1494.
|
[4] |
Lee SG, Song GW, Hwang S, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience[J].J Hepatobiliary Pancreat Sci, 2010, 17(4):476-489.
|
[5] |
Chen RX, Li CX, Luo CH, et al. Surgical strategies for the treatment of Bismuth type Ⅰ and Ⅱ hilar cholangiocarcinoma: bile duct resection with or without hepatectomy?[J]. Ann Surg Oncol, 2020, 27(9):3374-3382.
|
[6] |
Chen XP, Lau WY, Huang ZY, et al. Extent of liver resection for hilar cholangiocarcinoma[J]. Br J Surg, 2009, 96(10):1167-1175.
|
[7] |
Ikeyama T, Nagino M, Oda K, et al. Surgical approach to bismuth type Ⅰ and Ⅱ hilar cholangiocarcinomas: audit of 54 consecutive cases[J]. Ann Surg, 2007, 246(6):1052-1057.
|
[8] |
Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portalvein embolization[J]. Ann Surg, 2003, 238(1):84-92.
|
[9] |
Sugiura T, Okamura Y, Ito T, et al. Left hepatectomy with combined resection and reconstruction of right hepatic artery for Bismuth type Ⅰ and Ⅱ perihilar cholangiocarcinoma.[J]. World J Surg, 2019, 43(3): 894-901.
|
[10] |
Lee Y, Choi D, Han S, et al. Comparison analysis of left-side versus right-side resection in bismuth type Ⅲ hilar cholangiocarcinoma[J]. Ann Hepatobiliary Pancreat Surg, 2018, 22(4):350-358.
|
[11] |
Ebata T, Mizuno T, Yokoyama Y, et al. Surgical resection for Bismuth type Ⅳ perihilar cholangiocarcinoma[J]. Br J Surg, 2018, 105(7): 829-838.
|
[12] |
Matsumoto N, Ebata T, Yokoyama Y, et al. Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma[J]. Br J Surg, 2014, 101(3):261-268.
|
[13] |
Zaydfudim VM, Rosen CB, Nagorney DM. Hilar cholangiocarcinoma[J]. Surg Oncol Clin N Am, 2014, 23(2):247-263.
|
[14] |
Dumitrascu T, Brasoveanu V, Stroescu C, et al. Major hepatectomies for perihilar cholangiocarcinoma: predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions[J]. Asian J Surg, 2016, 39(2):81-89.
|
[15] |
Bhutiani N, Scoggins CR, McMasters KM, et al. The impact of caudate lobe resection on margin status and outcomes in patientswith hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium[J]. Surgery, 2018, 163(4):726-731.
|
[16] |
Juntermanns B, Kaiser GM, Reis H, et al. Long-term survival after resection for perihilar cholangiocarcinoma: impact of UICC staging and surgical procedure[J]. Turk J Gastroenterol, 2019, 30(5):454-460.
|
[17] |
Chen W, Ke K, Chen YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2014, 40(5):489-495.
|
[18] |
Schimizzi GV, Jin LX, Davidson 4th JT, et al. Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium[J]. HPB, 2018, 20(4): 332-339.
|
[19] |
Hemming AW, Mekeel K, Khanna A, et al. Portal vein resection in management of hilar cholangiocarcinoma[J]. J Am Coll Surg, 2011, 212(4):604-613.
|
[20] |
Takahashi Y, Nagino M, Nishio H, et al. Percutaneous transhepatic biliary drainage catheter tract recurrence incholangiocarcinoma[J]. Br J Surg, 2010, 97(12):1860-1866.
|
[21] |
Komaya K, Ebata T, Yokoyama Y, et al. Verification of the oncologic inferiority of percutaneous biliary drainage toendoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma[J]. Surgery, 2017, 161(2):394-404.
|
[22] |
Yamashita H, Ebata T, Yokoyama Y, et al. Pleural dissemination of cholangiocarcinoma caused by percutaneous transhepatic biliary drainage during the management of resectable cholangiocarcinoma[J]. Surgery, 2019, 165(5):912-917.
|
[23] |
Al Mahjoub A, Menahem B, Fohlen A, et al. Preoperative biliary drainage in patients with resectable perihilar cholangiocarcinoma: is percutaneous transhepatic biliary drainage safer and more effective than endoscopic biliary drainage? a meta-analysis[J]. J Vasc Interv Radiol, 2017, 28(4):576-582.
|
[24] |
Tang Z, Yang Y, Meng W, et al. Best option for preoperative biliary drainage in Klatskin tumor: a systematic review and meta-analysis[J]. Medicine, 2017, 96(43):e8372.
|
[25] |
Kawashima H, Itoh A, Ohno E, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy andrisk factors related to complications[J]. Ann Surg, 2013, 257(1): 121-127.
|
[26] |
Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J].J Gastroenterol, 2011, 46(2):242-248.
|
[27] |
Liu F, Li Y, Wei Y, et al. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? a systematic review[J]. Dig Dis Sci, 2011, 56(3):663-672.
|
[28] |
Coelen RJS, Ruys AT, Besselink MGH, et al. Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Surg Endosc, 2016, 30(10):4163-4173.
|
[29] |
Bird N, Elmasry M, Jones R, et al. Role of staging laparoscopy in the stratification of patients with perihilar cholangiocarcinoma[J]. Br J Surg, 2017, 104(4):418-425.
|
[30] |
Hu H, Wu Z, Jin Y, et al. Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives[J]. ANZ J Surg, 2019, 89(5):476-480.
|
[31] |
Lin E, Sarmiento JM. Laparoscopic extended right hepatectomy, portal lymphadenectomy, and hepaticojejunostomy for hilar cholangiocarcinoma[J]. J Laparoendosc Adv Surg Tech A, 2014, 24(6):411-416.
|
[32] |
腹腔镜肝门部胆管癌根治切除术操作规范专家组,中华外科杂志编辑部. 腹腔镜肝门部胆管癌根治性切除操作流程专家建议[J]. 中华外科杂志,2019,57(8):561-567.
|
[33] |
Sudan D, DeRoover A, Chinnakotla S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma[J]. Am J Transplant, 2002, 2(8):774-779.
|
[34] |
Ethun CG, Lopez-Aguiar AG, Anderson DJ, et al. Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease[J]. Ann Surg, 2018, 267(5):797-805.
|
[35] |
Moris D, Kostakis ID, Machairas N, et al. Comparison between liver transplantation and resection for hilar cholangiocarcinoma:a systematic review and meta-analysis[J]. PLoS One, 2019, 14(7): e220527.
|
[36] |
Hong JC, Jones CM, Duffy JP, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma[J]. Arch Surg, 2011, 146(6):683-689.
|
[37] |
Dondorf F, Uteß F, Fahrner R, et al. Liver transplant for perihilar cholangiocarcinoma (Klatskin tumor): the essential role of patient selection[J]. Exp Clin Transplant, 2019, 17(3):363-369.
|